Healius (ASX:HLS) Total Stockholders Equity: A$557 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:HLS Healius Ltd ASX:HLS
49 GF Score
Price A$0.38
GF Value A$1.02
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Healius Total Stockholders Equity?

Healius ASX:HLS -6.25% 49 Total Stockholders Equity is A$557 Mil as of Dec. 2025. GuruFocus rates ASX:HLS with a GF Score™ of 49/100 and a GF Value™ of A$1.02 (Possible Value Trap). The stock has 7 warning signs investors should review.

Healius's Total Stockholders Equity for the quarter that ended in Dec. 2025 was A$557 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Healius's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.77. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Healius's Debt-to-Equity for the quarter that ended in Dec. 2025 was 1.69.

Healius  (ASX:HLS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Healius's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(557.1-0)/726.133
=0.77

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Healius's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(178.7 + 761.4) / 557.1
=1.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healius Total Stockholders Equity Related Terms

Healius Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Healius's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healius Total Stockholders Equity Chart

Healius Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,857.30 1,921.60 1,506.20 1,040.70 587.90

Healius Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,050.30 1,040.70 1,026.80 587.90 557.10
ASX:HLS
49GF Score
Healius Ltd ASX:HLS
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of A$557 Mil mean?
Healius (ASX:HLS) has a Total Stockholders Equity of A$557 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Healius and its competitors.
Is Healius' Total Stockholders Equity too high?
Healius' current Total Stockholders Equity is A$557 Mil. Overall, Healius has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healius' Total Stockholders Equity compare to TMO and DHR?
Healius' Total Stockholders Equity of A$557 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Healius and its competitors. Healius's current Total Stockholders Equity is A$557 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healius stock overvalued right now?
Based on GuruFocus' analysis, Healius (ASX:HLS) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.02, compared to a current price of A$0.38 — trading 63.2% below its estimated fair value. The current Total Stockholders Equity is A$557 Mil. Healius' overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Healius (ASX:HLS), the current Total Stockholders Equity is A$557 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healius (ASX:HLS) Overvalued in 2026?

Based on GuruFocus' analysis, Healius stock appears to be undervalued. The current stock price of A$0.38 is trading 63.2% below its estimated GF Value™ of A$1.02. GuruFocus considers Healius to be Possible Value Trap.

Key valuation signals for ASX:HLS:

  • Total Stockholders Equity: A$557 Mil
  • GF Value™: A$1.02 vs. price of A$0.38 (63.2% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ASX:HLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healius Business Description

Other Exchanges PGZ:Germany
Address 161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
49GF Score

Get the complete analysis for ASX:HLS

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.38
Price
A$1.02
GF Value